535217 — HPC Biosciences Cashflow Statement
0.000.00%
Consumer DefensivesHighly SpeculativeMicro Cap
Annual cashflow statement for HPC Biosciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | R2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | Interim Report | PRESS | PRESS |
Standards: | IAS | IAS | IAS | — | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 5.77 | 3.59 | 11.9 | -4.81 | -4.13 |
Depreciation | |||||
Non-Cash Items | -0.715 | -1.02 | -0.854 | -4.17 | -3.72 |
Other Non-Cash Items | |||||
Changes in Working Capital | -0.475 | -0.438 | -2.45 | 4.8 | -0.658 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 11.7 | 8.23 | 13.7 | 0.851 | -3.48 |
Capital Expenditures | 0 | 0 | — | 0 | 0 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -9.63 | -7.92 | -13.7 | 8.11 | -3.53 |
Change in Net Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -9.63 | -7.92 | -13.7 | 8.11 | -3.53 |
Financing Cash Flow Items | 0 | 0 | 0 | 0 | 0 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0 | 0 | 0 | 0 | 0 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 2.12 | 0.305 | 0.029 | 8.96 | -7.01 |